Kurs & Likviditet
Kalender
| 2024-10-29 | Kvartalsrapport 2024-Q3 |
| 2024-10-15 | Halvårsutdelning ORNBV 0.81 |
| 2024-10-15 | Halvårsutdelning ORNAV 0.81 |
| 2024-08-08 | Kvartalsrapport 2024-Q2 |
| 2024-04-25 | Kvartalsrapport 2024-Q1 |
| 2024-03-21 | Halvårsutdelning ORNAV 0.81 |
| 2024-03-21 | Halvårsutdelning ORNBV 0.81 |
| 2024-03-20 | Årsstämma 2024 |
| 2024-02-13 | Bokslutskommuniké 2023 |
| 2023-10-26 | Kvartalsrapport 2023-Q3 |
| 2023-07-17 | Kvartalsrapport 2023-Q2 |
| 2023-04-27 | Kvartalsrapport 2023-Q1 |
| 2023-03-23 | Ordinarie utdelning ORNAV 1.60 EUR |
| 2023-03-23 | Ordinarie utdelning ORNBV 1.60 EUR |
| 2023-03-22 | Årsstämma 2023 |
| 2023-02-09 | Bokslutskommuniké 2022 |
| 2022-10-20 | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | Kvartalsrapport 2022-Q2 |
| 2022-04-28 | Kvartalsrapport 2022-Q1 |
| 2022-03-24 | Ordinarie utdelning ORNAV 1.50 EUR |
| 2022-03-24 | Ordinarie utdelning ORNBV 1.50 EUR |
| 2022-03-23 | Årsstämma 2022 |
| 2022-02-10 | Bokslutskommuniké 2021 |
| 2021-10-20 | Kvartalsrapport 2021-Q3 |
| 2021-07-19 | Kvartalsrapport 2021-Q2 |
| 2021-04-27 | Kvartalsrapport 2021-Q1 |
| 2021-03-26 | Ordinarie utdelning ORNBV 1.50 EUR |
| 2021-03-26 | Ordinarie utdelning ORNAV 1.50 EUR |
| 2021-03-25 | Årsstämma 2021 |
| 2021-02-09 | Bokslutskommuniké 2020 |
| 2020-10-21 | Kvartalsrapport 2020-Q3 |
| 2020-07-17 | Kvartalsrapport 2020-Q2 |
| 2020-05-07 | Ordinarie utdelning ORNBV 1.50 EUR |
| 2020-05-07 | Ordinarie utdelning ORNAV 1.50 EUR |
| 2020-05-06 | Årsstämma 2020 |
| 2020-04-28 | Kvartalsrapport 2020-Q1 |
| 2020-03-26 | Ordinarie utdelning ORNBV 1.50 EUR |
| 2020-02-05 | Bokslutskommuniké 2019 |
| 2019-10-23 | Kvartalsrapport 2019-Q3 |
| 2019-07-17 | Kvartalsrapport 2019-Q2 |
| 2019-04-25 | Kvartalsrapport 2019-Q1 |
| 2019-03-27 | Ordinarie utdelning ORNAV 1.50 EUR |
| 2019-03-27 | Ordinarie utdelning ORNBV 1.50 EUR |
| 2019-03-26 | Årsstämma 2019 |
| 2019-02-06 | Bokslutskommuniké 2018 |
| 2018-10-24 | Kvartalsrapport 2018-Q3 |
| 2018-07-18 | Kvartalsrapport 2018-Q2 |
| 2018-04-24 | Kvartalsrapport 2018-Q1 |
| 2018-03-21 | Ordinarie utdelning ORNBV 1.45 EUR |
| 2018-03-21 | Ordinarie utdelning ORNAV 1.45 EUR |
| 2018-03-20 | Årsstämma 2018 |
| 2018-02-07 | Bokslutskommuniké 2017 |
| 2017-10-26 | Kvartalsrapport 2017-Q3 |
| 2017-07-19 | Kvartalsrapport 2017-Q2 |
| 2017-05-18 | Kapitalmarknadsdag 2017 |
| 2017-04-26 | Kvartalsrapport 2017-Q1 |
| 2017-03-23 | Bonusutdelning ORNBV 0.2 |
| 2017-03-23 | Ordinarie utdelning ORNAV 1.35 EUR |
| 2017-03-23 | Bonusutdelning ORNAV 0.2 |
| 2017-03-23 | Ordinarie utdelning ORNBV 1.35 EUR |
| 2017-03-22 | Årsstämma 2017 |
| 2017-02-08 | Bokslutskommuniké 2016 |
| 2016-10-25 | Kvartalsrapport 2016-Q3 |
| 2016-07-19 | Kvartalsrapport 2016-Q2 |
| 2016-04-27 | Kvartalsrapport 2016-Q1 |
| 2016-03-23 | Ordinarie utdelning ORNAV 1.30 EUR |
| 2016-03-23 | Ordinarie utdelning ORNBV 1.30 EUR |
| 2016-03-22 | Årsstämma 2016 |
| 2016-02-02 | Bokslutskommuniké 2015 |
| 2015-10-27 | Kvartalsrapport 2015-Q3 |
| 2015-07-28 | Kvartalsrapport 2015-Q2 |
| 2015-05-26 | Kapitalmarknadsdag 2015 |
| 2015-04-29 | Kvartalsrapport 2015-Q1 |
| 2015-03-25 | Ordinarie utdelning ORNBV 1.30 EUR |
| 2015-03-25 | Ordinarie utdelning ORNAV 1.30 EUR |
| 2015-03-24 | Årsstämma 2015 |
| 2015-02-04 | Bokslutskommuniké 2014 |
| 2014-10-21 | Kvartalsrapport 2014-Q3 |
| 2014-07-29 | Kvartalsrapport 2014-Q2 |
| 2014-04-29 | Kvartalsrapport 2014-Q1 |
| 2014-03-26 | Ordinarie utdelning ORNBV 1.25 EUR |
| 2014-03-26 | Ordinarie utdelning ORNAV 1.25 EUR |
| 2014-03-25 | Årsstämma 2014 |
| 2014-02-04 | Bokslutskommuniké 2013 |
| 2013-10-22 | Kvartalsrapport 2013-Q3 |
| 2013-07-30 | Kvartalsrapport 2013-Q2 |
| 2013-04-23 | Kvartalsrapport 2013-Q1 |
| 2013-03-20 | Ordinarie utdelning ORNAV 1.30 EUR |
| 2013-03-20 | Ordinarie utdelning ORNBV 1.30 EUR |
| 2013-03-19 | Årsstämma 2013 |
| 2013-02-05 | Bokslutskommuniké 2012 |
| 2012-10-23 | Kvartalsrapport 2012-Q3 |
| 2012-07-31 | Kvartalsrapport 2012-Q2 |
| 2012-05-24 | Kapitalmarknadsdag 2012 |
| 2012-04-24 | Kvartalsrapport 2012-Q1 |
| 2012-03-21 | Ordinarie utdelning ORNBV 1.30 EUR |
| 2012-03-21 | Ordinarie utdelning ORNAV 1.30 EUR |
| 2012-03-21 | Bonusutdelning ORNAV 0.12 |
| 2012-03-21 | Bonusutdelning ORNBV 0.12 |
| 2012-03-20 | Årsstämma 2012 |
| 2012-02-07 | Bokslutskommuniké 2011 |
| 2011-10-25 | Kvartalsrapport 2011-Q3 |
| 2011-08-02 | Kvartalsrapport 2011-Q2 |
| 2011-04-27 | Kvartalsrapport 2011-Q1 |
| 2011-04-01 | Bonusutdelning ORNAV 0.06 |
| 2011-04-01 | Ordinarie utdelning ORNAV 1.20 EUR |
| 2011-04-01 | Ordinarie utdelning ORNBV 1.20 EUR |
| 2011-04-01 | Bonusutdelning ORNBV 0.06 |
| 2011-03-31 | Årsstämma 2011 |
| 2011-02-09 | Bokslutskommuniké 2010 |
| 2010-10-26 | Kvartalsrapport 2010-Q3 |
| 2010-08-10 | Kvartalsrapport 2010-Q2 |
| 2010-04-27 | Kvartalsrapport 2010-Q1 |
| 2010-03-25 | Bonusutdelning ORNBV 0.1 |
| 2010-03-25 | Ordinarie utdelning ORNBV 1.00 EUR |
| 2010-03-25 | Ordinarie utdelning ORNAV 1.00 EUR |
| 2010-03-25 | Bonusutdelning ORNAV 0.1 |
| 2009-03-24 | Ordinarie utdelning ORNBV 0.95 EUR |
| 2009-03-24 | Ordinarie utdelning ORNAV 0.95 EUR |
| 2008-03-26 | Ordinarie utdelning ORNBV 1.00 EUR |
| 2007-04-03 | Ordinarie utdelning ORNAV 1.00 EUR |
| 2007-04-03 | Ordinarie utdelning ORNBV 1.00 EUR |
| 2006-03-22 | Ordinarie utdelning ORNBV 0.85 EUR |
| 2005-03-22 | Ordinarie utdelning ORNAV 0.55 EUR |
| 2005-03-22 | Ordinarie utdelning ORNBV 0.55 EUR |
| 2004-09-15 | Bonusutdelning ORNBV 2.14 |
| 2004-09-15 | Bonusutdelning ORNAV 2.14 |
| 2004-03-23 | Ordinarie utdelning ORNAV 1.60 EUR |
| 2004-03-23 | Ordinarie utdelning ORNBV 1.60 EUR |
| 2003-12-12 | Bonusutdelning ORNBV 1.5 |
| 2003-12-12 | Bonusutdelning ORNAV 1.5 |
| 2003-03-23 | Ordinarie utdelning ORNAV 0.93 EUR |
| 2003-03-23 | Ordinarie utdelning ORNBV 0.93 EUR |
| 2002-04-16 | Ordinarie utdelning ORNAV 1.10 EUR |
| 2002-04-16 | Ordinarie utdelning ORNBV 1.10 EUR |
| 2001-03-30 | Ordinarie utdelning ORNAV 1.20 EUR |
| 2001-03-30 | Ordinarie utdelning ORNBV 1.20 EUR |
| 2000-03-31 | Ordinarie utdelning ORNBV 1.18 EUR |
| 2000-03-31 | Ordinarie utdelning ORNAV 1.18 EUR |
| 1999-07-28 | Bonusutdelning ORNBV 13.46 |
| 1999-07-28 | Bonusutdelning ORNAV 13.46 |
| 1999-04-09 | Ordinarie utdelning ORNAV 6.50 EUR |
| 1999-04-09 | Ordinarie utdelning ORNBV 6.50 EUR |
| 1998-04-21 | Ordinarie utdelning ORNBV 7.50 EUR |
| 1998-04-21 | Ordinarie utdelning ORNAV 7.50 EUR |
| 1997-04-22 | Ordinarie utdelning ORNBV 5.00 EUR |
| 1997-04-22 | Ordinarie utdelning ORNAV 5.00 EUR |
| 1996-04-23 | Ordinarie utdelning ORNAV 4.00 EUR |
| 1996-04-23 | Ordinarie utdelning ORNBV 4.00 EUR |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Large Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
STOCK EXCHANGE RELEASE / CHANGES IN COMPANY’S OWN SHARES
1 MARCH 2023 at 20.30 EET
Orion Corporation: Transfer of 149,798 own B shares on 1 March 2023
In accordance with a decision by the Board of Directors, Orion Corporation has on 1 March 2023 transferred altogether 149,798 Orion Corporation B shares held by the company as a share reward for earning period 2020–2022 to the persons belonging to the Share-based Incentive Plan of the Orion Group. The transfer is based on the authorisation by the Annual General Meeting of 23 March 2022.
The price per share of the transferred shares is EUR 44.2606, which is the volume weighted average quotation of the Orion Corporation B share on 1 March 2023. Accordingly, the total transaction price of the transferred shares is EUR 6,630,149.36.
After the share transfer, the total number of own B shares held by Orion Corporation is 782,973.
Orion Corporation has informed about the Share-based Incentive Plan in stock exchange release on 6 February 2019.
Orion Corporation
| Liisa Hurme President and CEO | | Olli Huotari SVP, Corporate Functions | |
Contact person:
Olli Huotari, SVP, Corporate Functions, tel. +358 10 426 3054, mobile +358 50 966 3054
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
http://www.orion.fi/en
http://www.twitter.com/OrionCorpIR
Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Orion has an extensive portfolio of proprietary and generic medicines and self-care products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion are used to treat cancer, neurological diseases and respiratory diseases, among others. Orion's net sales in 2022 amounted to EUR 1,341 million and the company had about 3,500 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.